US Stock MarketDetailed Quotes

ADIL Adial Pharmaceuticals

Watchlist
  • 1.0200
  • -0.0300-2.86%
Close Dec 27 16:00 ET
  • 1.0500
  • +0.0300+2.94%
Post 20:01 ET
6.60MMarket Cap-0.31P/E (TTM)

Adial Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
62.86%2.21M
54.82%2.29M
-18.68%1.85M
-36.57%6.89M
-31.32%1.78M
-46.84%1.36M
-54.45%1.48M
-25.83%2.27M
-38.79%10.86M
-41.40%2.6M
Selling and administrative expenses
2.52%1.18M
21.69%1.27M
-26.92%1.39M
-36.91%5.62M
-26.44%1.52M
-38.08%1.15M
-59.14%1.05M
-22.72%1.9M
-4.66%8.91M
-1.61%2.07M
-General and administrative expense
2.52%1.18M
21.69%1.27M
-26.92%1.39M
-36.91%5.62M
-26.44%1.52M
-38.08%1.15M
-59.14%1.05M
-22.72%1.9M
-4.66%8.91M
-1.61%2.07M
Research and development costs
398.07%1.03M
135.53%1.01M
24.25%454.28K
-35.03%1.27M
-50.28%264.44K
-70.24%207.13K
-36.78%429.9K
-38.69%365.62K
-76.77%1.95M
-77.21%531.84K
Operating profit
-62.86%-2.21M
-54.82%-2.29M
18.68%-1.85M
36.57%-6.89M
31.32%-1.78M
46.84%-1.36M
54.45%-1.48M
25.83%-2.27M
38.79%-10.86M
41.40%-2.6M
Net non-operating interest income expense
395.25%50.69K
164.61%51.4K
-21.08%22.8K
10.17%69.78K
-76.53%11.23K
194.82%10.24K
180.32%19.43K
464.85%28.89K
868.62%63.34K
2,072.69%47.82K
Non-operating interest income
395.25%50.69K
164.61%51.4K
-21.08%22.8K
10.17%69.78K
-76.53%11.23K
194.82%10.24K
180.32%19.43K
464.85%28.89K
868.62%63.34K
2,072.69%47.82K
Other net income (expense)
-31.02K
-328.65%-222.47K
-4.65M
-183.72K
-131.82K
-51.9K
Gain on sale of security
----
----
---4.46M
----
----
----
----
----
----
----
Earnings from equity interest
---31.02K
---222.47K
---189.87K
---193.88K
----
--0
--0
--0
--0
----
Special income (charges)
--0
----
----
----
----
--0
----
----
----
----
Other non- operating income (expenses)
----
----
---42
--10.16K
--62.06K
----
---51.9K
----
----
----
Income before tax
-62.63%-2.19M
-62.82%-2.46M
-189.15%-6.48M
35.14%-7M
25.31%-1.9M
47.17%-1.35M
53.35%-1.51M
22.97%-2.24M
44.68%-10.8M
56.97%-2.55M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
-58.26%-2.19M
-325.99%-2.46M
-122.88%-6.48M
59.76%-5.12M
33.01%-1.92M
55.46%-1.38M
128.27%1.09M
0.07%-2.91M
34.45%-12.73M
50.84%-2.87M
Net income continuous Operations
-62.63%-2.19M
-62.82%-2.46M
-189.15%-6.48M
35.14%-7M
25.31%-1.9M
47.17%-1.35M
53.35%-1.51M
22.97%-2.24M
44.42%-10.8M
56.27%-2.55M
Net income discontinuous operations
--0
--0
--0
197.07%1.88M
94.99%-15.9K
93.32%-37.28K
525.39%2.6M
---665.95K
---1.94M
---317.02K
Minority interest income
Net income attributable to the parent company
-58.26%-2.19M
-325.99%-2.46M
-122.88%-6.48M
59.76%-5.12M
33.01%-1.92M
55.46%-1.38M
128.27%1.09M
0.07%-2.91M
34.45%-12.73M
50.84%-2.87M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-58.26%-2.19M
-325.99%-2.46M
-122.88%-6.48M
59.76%-5.12M
33.01%-1.92M
55.46%-1.38M
128.27%1.09M
0.07%-2.91M
34.45%-12.73M
50.84%-2.87M
Basic earnings per share
67.80%-0.38
-161.46%-0.59
20.36%-2.19
71.68%-3.6
58.32%-1.1544
60.93%-1.18
124.24%0.96
15.38%-2.75
51.12%-12.71
60.43%-2.77
Diluted earnings per share
67.80%-0.38
-161.46%-0.59
20.36%-2.19
71.68%-3.6
58.32%-1.1544
60.93%-1.18
124.24%0.96
15.38%-2.75
51.12%-12.71
60.43%-2.77
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 62.86%2.21M54.82%2.29M-18.68%1.85M-36.57%6.89M-31.32%1.78M-46.84%1.36M-54.45%1.48M-25.83%2.27M-38.79%10.86M-41.40%2.6M
Selling and administrative expenses 2.52%1.18M21.69%1.27M-26.92%1.39M-36.91%5.62M-26.44%1.52M-38.08%1.15M-59.14%1.05M-22.72%1.9M-4.66%8.91M-1.61%2.07M
-General and administrative expense 2.52%1.18M21.69%1.27M-26.92%1.39M-36.91%5.62M-26.44%1.52M-38.08%1.15M-59.14%1.05M-22.72%1.9M-4.66%8.91M-1.61%2.07M
Research and development costs 398.07%1.03M135.53%1.01M24.25%454.28K-35.03%1.27M-50.28%264.44K-70.24%207.13K-36.78%429.9K-38.69%365.62K-76.77%1.95M-77.21%531.84K
Operating profit -62.86%-2.21M-54.82%-2.29M18.68%-1.85M36.57%-6.89M31.32%-1.78M46.84%-1.36M54.45%-1.48M25.83%-2.27M38.79%-10.86M41.40%-2.6M
Net non-operating interest income expense 395.25%50.69K164.61%51.4K-21.08%22.8K10.17%69.78K-76.53%11.23K194.82%10.24K180.32%19.43K464.85%28.89K868.62%63.34K2,072.69%47.82K
Non-operating interest income 395.25%50.69K164.61%51.4K-21.08%22.8K10.17%69.78K-76.53%11.23K194.82%10.24K180.32%19.43K464.85%28.89K868.62%63.34K2,072.69%47.82K
Other net income (expense) -31.02K-328.65%-222.47K-4.65M-183.72K-131.82K-51.9K
Gain on sale of security -----------4.46M----------------------------
Earnings from equity interest ---31.02K---222.47K---189.87K---193.88K------0--0--0--0----
Special income (charges) --0------------------0----------------
Other non- operating income (expenses) -----------42--10.16K--62.06K-------51.9K------------
Income before tax -62.63%-2.19M-62.82%-2.46M-189.15%-6.48M35.14%-7M25.31%-1.9M47.17%-1.35M53.35%-1.51M22.97%-2.24M44.68%-10.8M56.97%-2.55M
Income tax 0000000000
Net income -58.26%-2.19M-325.99%-2.46M-122.88%-6.48M59.76%-5.12M33.01%-1.92M55.46%-1.38M128.27%1.09M0.07%-2.91M34.45%-12.73M50.84%-2.87M
Net income continuous Operations -62.63%-2.19M-62.82%-2.46M-189.15%-6.48M35.14%-7M25.31%-1.9M47.17%-1.35M53.35%-1.51M22.97%-2.24M44.42%-10.8M56.27%-2.55M
Net income discontinuous operations --0--0--0197.07%1.88M94.99%-15.9K93.32%-37.28K525.39%2.6M---665.95K---1.94M---317.02K
Minority interest income
Net income attributable to the parent company -58.26%-2.19M-325.99%-2.46M-122.88%-6.48M59.76%-5.12M33.01%-1.92M55.46%-1.38M128.27%1.09M0.07%-2.91M34.45%-12.73M50.84%-2.87M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -58.26%-2.19M-325.99%-2.46M-122.88%-6.48M59.76%-5.12M33.01%-1.92M55.46%-1.38M128.27%1.09M0.07%-2.91M34.45%-12.73M50.84%-2.87M
Basic earnings per share 67.80%-0.38-161.46%-0.5920.36%-2.1971.68%-3.658.32%-1.154460.93%-1.18124.24%0.9615.38%-2.7551.12%-12.7160.43%-2.77
Diluted earnings per share 67.80%-0.38-161.46%-0.5920.36%-2.1971.68%-3.658.32%-1.154460.93%-1.18124.24%0.9615.38%-2.7551.12%-12.7160.43%-2.77
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.